Skip to content

A Clinical Comparison of Two Multifocal Toric Soft Contact Lenses

A Clinical Comparison of Two Multifocal Toric Soft Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06438601
Enrollment
36
Registered
2024-06-03
Start date
2024-04-24
Completion date
2024-08-15
Last updated
2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Presbyopia

Brief summary

This study aims to compare the short-term clinical performance of the two study contact lenses.

Detailed description

The aim of this study is to evaluate the short-term clinical performance of two multifocal toric soft contact lenses after 15 minutes of daily wear each.

Interventions

DEVICELens A (omafilcon A)

15 minutes of daily wear.

15 minutes of daily wear.

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
35 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. They are aged 35 years or over and have capacity to volunteer. 2. They understand their rights as a subject and are willing to sign a Statement of Informed Consent. 3. They are willing and able to follow the protocol. 4. They agree not to participate in other clinical research for the duration of this study. 5. They are currently wearing soft contact lenses or have done so within the past 12 months. 6. They have a spherical prescription between +10.00 and -10.00DS inclusive, (based on the ocular refraction). 7. They have astigmatism of between -0.75 and -5.75DC (based on the ocular refraction) in each eye. 8. They have a reading addition component to their spectacle refraction of between +0.75 and +2.50DS. 9. They can be satisfactorily fitted with the study lenses. 10. They own a wearable pair of spectacles.

Exclusion criteria

1. They have an ocular disorder which would normally contraindicate contact lens wear. 2. They have a systemic disorder which would normally contra-indicate contact lens wear. 3. They are using any topical medications such as eye drops or ointment. 4. They have had cataract surgery. 5. They have had corneal refractive surgery. 6. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus. 7. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear. 8. They have eye or health conditions including immunosuppressive or infectious diseases which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or a history of anaphylaxis or severe allergic reaction. 9. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Distance VisionAt the end of 15 minutes of daily wearSubjective Distance Vision will be measured on a scale from 0-100 (Where 0= Extremely poor. Intolerable. Lenses cannot be worn. 100= Excellent. Unaware of any visual loss).

Countries

United Kingdom

Participant flow

Pre-assignment details

Forty participants were screened. Of those, four participants were ineligible and excluded from the study. Thirty-six participants were enrolled.

Participants by arm

ArmCount
All Study Participants
Includes all enrolled participants
36
Total36

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1: Lens A (15 Minutes)Use of eye drops between study visits10
Period 1: Lens A (15 Minutes)Withdrawal by Subject10

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous53.7 years
STANDARD_DEVIATION 8.3
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 360 / 340 / 36
other
Total, other adverse events
0 / 360 / 342 / 36
serious
Total, serious adverse events
0 / 360 / 340 / 36

Outcome results

Primary

Subjective Distance Vision

Subjective Distance Vision will be measured on a scale from 0-100 (Where 0= Extremely poor. Intolerable. Lenses cannot be worn. 100= Excellent. Unaware of any visual loss).

Time frame: At the end of 15 minutes of daily wear

Population: All participants that completed the study.

ArmMeasureValue (MEAN)Dispersion
Lens A (Omafilcon A)Subjective Distance Vision77.1 units on a scaleStandard Deviation 19.6
Lens B (Comfilcon A)Subjective Distance Vision80.0 units on a scaleStandard Deviation 14.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026